id stringlengths 8 8 | name stringlengths 5 37 | translator_id stringlengths 9 29 | drugbank_id stringlengths 7 12 ⌀ | synonyms listlengths 0 7 | aggregated_with listlengths 0 13 | drug_class stringlengths 4 79 ⌀ | therapeutic_area stringclasses 98
values | drug_function stringlengths 5 201 ⌀ | drug_target stringlengths 2 221 ⌀ | approved_usa stringclasses 3
values | is_antipsychotic bool 2
classes | is_sedative bool 2
classes | is_antimicrobial bool 2
classes | is_glucose_regulator bool 2
classes | is_chemotherapy bool 2
classes | is_steroid bool 2
classes | is_analgesic bool 2
classes | is_cardiovascular bool 2
classes | is_cell_therapy bool 2
classes | atc_main stringlengths 7 7 ⌀ | atc_level_1 stringclasses 14
values | atc_level_2 stringclasses 79
values | atc_level_3 stringclasses 167
values | atc_level_4 stringlengths 5 5 ⌀ | atc_level_5 stringlengths 7 7 ⌀ | l1_label stringclasses 14
values | l2_label stringclasses 79
values | l3_label stringclasses 167
values | l4_label stringlengths 6 102 ⌀ | l5_label stringlengths 5 28 ⌀ | deleted bool 2
classes | deleted_reason stringclasses 8
values | new_id stringclasses 4
values | is_fda_generic_drug bool 2
classes | __index_level_0__ int64 0 1.82k |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EC:00001 | Abacavir | CHEBI:421707 | DB01048 | [] | [] | Nucleoside reverse transcriptase inhibitor | Antimicrobial | Antiviral | HIV | APPROVED | false | false | true | false | false | false | false | false | false | J05AF06 | J | J05 | J05A | J05AF | J05AF06 | Antiinfectives for systemic use | Antivirals for systemic use | Direct acting antivirals | Nucleoside and nucleotide reverse transcriptase inhibitors | Abacavir | false | null | null | true | 0 |
EC:00002 | Abaloparatide | UNII:AVK0I6HY2U | DB05084 | [] | [] | Parathyroid hormone analog | Endocrine; Musculoskeletal | Activates osteoblasts | parathyroid hormone-related protein (PTHrP) analog | APPROVED | false | false | false | false | false | false | false | false | false | H05AA04 | H | H05 | H05A | H05AA | H05AA04 | Systemic hormonal preparations, excl. sex hormones and insulins | Calcium homeostasis | Parathyroid hormones and analogues | Parathyroid hormones and analogues | Abaloparatide | false | null | null | false | 1 |
EC:00003 | Abatacept | UNII:7D0YB67S97 | DB01281 | [] | [] | Selective T-cell costimulation blocker | Immune | Immunomodulator | Selective T-cell costimualation modulator | binds to CD80 and CD86 on APCs, preventing them from binding to CD28 on T-cells. | APPROVED | false | false | false | false | false | false | false | false | false | L04AA24 | L | L04 | L04A | L04AA | L04AA24 | Antineoplastic and immunomodulating agents | Immunosuppressants | Immunosuppressants | Selective immunosuppressants | Abatacept | false | null | null | false | 2 |
EC:00004 | Abemaciclib | CHEBI:233362 | DB12001 | [] | [] | CDK4/6 inhibitor | Targeted cancer therapy | Small molecule inhibitor | CDK4 and CDK6 inhibitor | APPROVED | false | false | false | false | false | false | false | false | false | L01EF03 | L | L01 | L01E | L01EF | L01EF03 | Antineoplastic and immunomodulating agents | Antineoplastic agents | Protein kinase inhibitors, antineoplastic and immunomodulating agents | Cyclin-dependent kinase (cdk) inhibitors | Abemaciclib | false | null | null | false | 3 |
EC:00005 | Abiraterone | CHEBI:68642 | DB05812 | [
"Abiraterone acetate"
] | [] | Androgen synthesis inhibitor | Targeted cancer therapy | Hormonal chemotherapy | CYP17 enzyme inhibitor to inhibit testerone production | APPROVED | false | false | false | false | false | false | false | false | false | L02BX03 | L | L02 | L02B | L02BX | L02BX03 | Antineoplastic and immunomodulating agents | Endocrine therapy antineoplastic and immunomodulating agents | Hormone antagonists and related agents | Other hormone antagonists and related agents in atc | Abiraterone | false | null | null | true | 4 |
EC:00006 | Abrocitinib | UNII:73SM5SF3OR | DB14973 | [] | [] | JAK inhibitor | Immune | Immunosuppressant | JAK1 inhibitor | APPROVED | false | false | false | false | false | false | false | false | false | D11AH08 | D | D11 | D11A | D11AH | D11AH08 | Dermatologicals | Other dermatological preparations in atc | Other dermatological preparations in atc | Agents for dermatitis, excluding corticosteroids | Abrocitinib | false | null | null | false | 5 |
EC:00007 | Acalabrutinib | CHEBI:167707 | DB11703 | [] | [] | BTK inhibitor | Targeted cancer therapy | Small molecule inhibitor | BTK inhibitor | APPROVED | false | false | false | false | false | false | false | false | false | L01EL02 | L | L01 | L01E | L01EL | L01EL02 | Antineoplastic and immunomodulating agents | Antineoplastic agents | Protein kinase inhibitors, antineoplastic and immunomodulating agents | Bruton's tyrosine kinase (btk) inhibitors | Acalabrutinib | false | null | null | false | 6 |
EC:00008 | Acamprosate | CHEBI:51041 | DB00659 | [
"Acamprosate calcium"
] | [] | Alcohol abstinence tool | Central nervous system | Reduce alcohol cravings | GABA agonist and partial NMDA antagonist | APPROVED | false | false | false | false | false | false | false | false | false | N07BB03 | N | N07 | N07B | N07BB | N07BB03 | Nervous system drugs | Other nervous system drugs in atc | Drugs used in addictive disorders | Drugs used in alcohol dependence | Acamprosate | false | null | null | true | 7 |
EC:00009 | Acarbose | UNII:T58MSI464G | DB00284 | [] | [] | α-glucosidase inhibitor | Endocrine | Antidiabetic | α-glucosidase inhibitor | APPROVED | false | false | false | true | false | false | false | false | false | null | null | null | null | null | null | null | null | null | null | null | false | null | null | true | 8 |
EC:00010 | Acebutolol | CHEBI:2379 | DB01193 | [] | [] | Beta blocker | Cardiovascular | Antihypertensive | Beta-1 antagonist | APPROVED | false | false | false | false | false | false | false | true | false | C07AB04 | C | C07 | C07A | C07AB | C07AB04 | Cardiovascular system drugs | Beta-adrenergic blocking agents | Beta blocking agents | Beta blocking agents, selective | Acebutolol | false | null | null | true | 9 |
EC:00011 | Aceclofenac | CHEBI:31159 | DB06736 | [] | [] | NSAID | Immune | Antiinflammatory | Prostaglandin G/H synthase inhibitor | NOT_APPROVED | false | false | false | false | false | false | true | false | false | M01AB16 | M | M01 | M01A | M01AB | M01AB16 | Musculo-skeletal system drugs | Antiinflammatory and antirheumatic products | Antiinflammatory and antirheumatic products, non-steroids | Acetic acid derivatives and related substances | Aceclofenac | false | null | null | false | 10 |
EC:00012 | Acenocoumarol | CHEBI:53766 | DB01418 | [] | [] | Vitamin K antagonist | Hematology | Anticoagulant | Vitamin K antagonist | NOT_APPROVED | false | false | false | false | false | false | false | false | false | null | null | null | null | null | null | null | null | null | null | null | false | null | null | false | 11 |
EC:00013 | Acetaminophen | CHEBI:46195 | DB00316 | [
"Paracetamol"
] | [] | Other analgesic | Misc | Analgesic | null | APPROVED | false | false | false | false | false | false | true | false | false | null | null | null | null | null | null | null | null | null | null | null | false | null | null | true | 12 |
EC:00014 | Acetazolamide | CHEBI:27690 | DB00819 | [] | [] | Carbonic anhydrase inhibitor | Renal | Diuretic, ophthlamic, antiseizure | Carbonic anhydase inhibitor | APPROVED | false | false | false | false | false | false | false | false | false | null | null | null | null | null | null | null | null | null | null | null | false | null | null | true | 13 |
EC:00015 | Acetylcysteine | CHEBI:28939 | DB06151 | [
"N-acetylcysteine"
] | [] | Mucolytic agent | Respiratory; detoxifying agent | Mucolytic agent | Mech not known | APPROVED | false | false | false | false | false | false | false | false | false | null | null | null | null | null | null | null | null | null | null | null | false | null | null | true | 14 |
EC:00016 | Acipimox | CHEBI:94688 | DB09055 | [] | [] | Nicotinic acid derivative | Cardiovascular; Metabolic | Antilipemic agent | Inhibits triglyceride production | NOT_APPROVED | false | false | false | false | false | false | false | true | false | C10AD06 | C | C10 | C10A | C10AD | C10AD06 | Cardiovascular system drugs | Lipid modifying agents | Lipid modifying agents, plain | Nicotinic acid and derivatives, lipid modifying, plain | Acipimox | false | null | null | false | 15 |
EC:00017 | Acitretin | CHEBI:50173 | DB00459 | [] | [] | Retinoid | Dermatology | null | Second gen retinoid | APPROVED | false | false | false | false | false | false | false | false | false | D05BB02 | D | D05 | D05B | D05BB | D05BB02 | Dermatologicals | Antipsoriatics | Antipsoriatics for systemic use | Retinoids for treatment of psoriasis | Acitretin | false | null | null | true | 16 |
EC:00018 | Aclidinium | CHEBI:65346 | DB08897 | [
"Aclidinium bromide"
] | [] | Inhaled antimuscarinic (LAMA) | Respiratory | Bronchodilator | M3 antagonist, long-acting | APPROVED | false | false | false | false | false | false | false | false | false | null | null | null | null | null | null | null | null | null | null | null | false | null | null | false | 17 |
EC:00019 | Acoltremon | UNII:1L7BVT4Z4Z | DB19202 | [] | [] | TRPM8 agonist | Ophthalmic | Increases tear production | Transient receptor potential melastatin 8 thermoreceptor (TRPM8) agonist | APPROVED | false | false | false | false | false | false | false | false | false | null | null | null | null | null | null | null | null | null | null | null | false | null | null | false | 18 |
EC:00020 | Acoramidis | UNII:T12B44A1OE | DB17999 | [] | [] | Transthyretin (TTR) Stabilizer | Cardiovascular | Anti-amyloid | TTR stabilizer | APPROVED | false | false | false | false | false | false | false | true | false | C01EB25 | C | C01 | C01E | C01EB | C01EB25 | Cardiovascular system drugs | Cardiac therapy drugs | Other cardiac preparations in atc | Other plain cardiac preparations in atc | null | false | null | null | false | 19 |
EC:00021 | Acrivastine | CHEBI:83168 | DB09488 | [] | [] | Histamine H1 antagonist | Immune | Antihistamine | Histamine H1 Antagonist | NOT_APPROVED | false | false | false | false | false | false | false | false | false | R06AX18 | R | R06 | R06A | R06AX | R06AX18 | Respiratory system drugs | Antihistamines for systemic use | Antihistamines for systemic use | Other antihistamines for systemic use in atc | Acrivastine | false | null | null | false | 20 |
EC:00022 | Acyclovir | CHEBI:2453 | DB00787 | [
"Aciclovir"
] | [
"Valacyclovir",
"Valaciclovir"
] | Viral DNA synthesis inhibitor | Antimicrobial | Antiviral | Herpes virus | APPROVED | false | false | true | false | false | false | false | false | false | null | null | null | null | null | null | null | null | null | null | null | false | null | null | true | 21 |
EC:00023 | Adagrasib | CHEBI:233309 | DB15568 | [] | [] | KRAS G12C inhibitor | Targeted cancer therapy | Small molecule inhibitor | KRAS G12C Inhibitor | APPROVED | false | false | false | false | false | false | false | false | false | L01XX77 | L | L01 | L01X | L01XX | L01XX77 | Antineoplastic and immunomodulating agents | Antineoplastic agents | Other antineoplastic agents in atc | Other antineoplastic agents in atc | Adagrasib | false | null | null | false | 22 |
EC:00024 | Adalimumab | UNII:FYS6T7F842 | DB00051 | [] | [] | Anti-TNF | Immune | Immunosuppressant | anti-TNF-alpha | APPROVED | false | false | false | false | false | false | false | false | false | L04AB04 | L | L04 | L04A | L04AB | L04AB04 | Antineoplastic and immunomodulating agents | Immunosuppressants | Immunosuppressants | Tumor necrosis factor alpha (tnf-alpha) inhibitors | Adalimumab | false | null | null | true | 23 |
EC:00025 | Adapalene | CHEBI:31174 | DB00210 | [] | [] | Retinoid | Dermatology | null | Retinoid-like | APPROVED | false | false | false | false | false | false | false | false | false | D10AD03 | D | D10 | D10A | D10AD | D10AD03 | Dermatologicals | Anti-acne preparations | Anti-acne preparations for topical use | Retinoids for topical use in acne | Adapalene | false | null | null | true | 24 |
EC:00026 | Adefovir | CHEBI:2469 | DB13868 | [
"Adefovir dipivoxil"
] | [] | Viral DNA synthesis inhibitor | Antimicrobial | Antiviral | HBV | APPROVED | false | false | true | false | false | false | false | false | false | null | null | null | null | null | null | null | null | null | null | null | false | null | null | true | 25 |
EC:00027 | Adenosine | CHEBI:16335 | DB00640 | [] | [] | Class V antiarrhythmic | Cardiovascular | Antiarrhythmic | Adenosine receptor | APPROVED | false | false | false | false | false | false | false | true | false | C01EB10 | C | C01 | C01E | C01EB | C01EB10 | Cardiovascular system drugs | Cardiac therapy drugs | Other cardiac preparations in atc | Other plain cardiac preparations in atc | Adenosine | false | null | null | true | 26 |
EC:00028 | Aducanumab | UNII:105J35OE21 | DB12274 | [] | [] | Anti-amyloid antibody | Central nervous system | Antidementia | Anti-amyloid | DISCONTINUED | false | false | false | false | false | false | false | false | false | N06DX03 | N | N06 | N06D | N06DX | N06DX03 | Nervous system drugs | Psychoanaleptics | Anti-dementia drugs | Other anti-dementia drugs in atc | Aducanumab | false | null | null | false | 27 |
EC:00029 | Afamelanotide | CHEBI:136034 | DB04931 | [] | [] | Melanocortin receptor agonist | Dermatology | null | melanocortin receptor agonist | APPROVED | false | false | false | false | false | false | false | false | false | D02BB02 | D | D02 | D02B | D02BB | D02BB02 | Dermatologicals | Emollients and protectives | Protectives against uv-radiation | Protectives against uv-radiation for systemic use | Afamelanotide | false | null | null | false | 28 |
EC:00030 | Afamitresgene autoleucel | DRUGBANK:DB18592 | DB18592 | [] | [] | Cell therapy | Cell therapy | TCR cell therapy | Targeting MAGE-A4 protein | APPROVED | false | false | false | false | false | false | false | false | true | null | null | null | null | null | null | null | null | null | null | null | false | null | null | false | 29 |
EC:00031 | Afatinib | CHEBI:61390 | DB08916 | [] | [] | EGFR inhibitor | Targeted cancer therapy | Small molecule inhibitor | EGFR, RTK | APPROVED | false | false | false | false | false | false | false | false | false | L01EB03 | L | L01 | L01E | L01EB | L01EB03 | Antineoplastic and immunomodulating agents | Antineoplastic agents | Protein kinase inhibitors, antineoplastic and immunomodulating agents | Epidermal growth factor receptor (egfr) tyrosine kinase inhibitors | Afatinib | false | null | null | false | 30 |
EC:00032 | Aflibercept | UNII:15C2VL427D | DB08885 | [
"Ziv-aflibercept"
] | [] | VEGF inhibitor | Ophthalmic; Targeted cancer therapy | Small molecule inhibitor | VEGF inhibitor | APPROVED | false | false | false | false | false | false | false | false | false | S01LA05 | S | S01 | S01L | S01LA | S01LA05 | Sensory organ drugs | Ophthalmologicals | Ocular vascular disorder agents | Antineovascularisation agents | Aflibercept | false | null | null | true | 31 |
EC:00033 | Agalsidase alfa | UNII:2HLC17MX9G | DB15874 | [
"Recombinant human alpha-galactosidase a",
"Alpha galactosidase",
"Agalsidase beta"
] | [] | Alpha-galactosidase replacement | Metabolic | Lysosomal enzyme replacement | Alpha-galactosidase replacement | NOT_APPROVED | false | false | false | false | false | false | false | false | false | A16AB03 | A | A16 | A16A | A16AB | A16AB03 | Alimentary tract and metabolism drugs | Other alimentary tract and metabolism products in atc | Other alimentary tract and metabolism products in atc | Enzymes for alimentary tract and metabolism | Agalsidase alfa | false | null | null | false | 32 |
EC:00034 | Agomelatine | CHEBI:134990 | DB06594 | [] | [] | Atypical antidepressant | Central nervous system | Antidepressant | Melatonergic agonist and serotonergic antagonist | NOT_APPROVED | false | false | false | false | false | false | false | false | false | N06AX22 | N | N06 | N06A | N06AX | N06AX22 | Nervous system drugs | Psychoanaleptics | Antidepressants | Other antidepressants in atc | Agomelatine | false | null | null | false | 33 |
EC:00035 | Albendazole | CHEBI:16664 | DB00518 | [] | [] | Antihelminthic | Antimicrobial | Antiparasitic | Antihelminthic | APPROVED | false | false | true | false | false | false | false | false | false | P02CA03 | P | P02 | P02C | P02CA | P02CA03 | Antiparasitic products, insecticides and repellents | Anthelmintics | Antinematodal agents | Benzimidazole derivatives, antinematodal | Albendazole | false | null | null | true | 34 |
EC:00036 | Albuterol | CHEBI:2549 | DB01001 | [
"Salbutamol"
] | [] | Short acting beta-2 agonist | Respiratory | bronchodilator | Beta-2 agonist | APPROVED | false | false | false | false | false | false | false | false | false | null | null | null | null | null | null | null | null | null | null | null | false | null | null | true | 35 |
EC:00037 | Alcaftadine | CHEBI:71023 | DB06766 | [] | [] | Histamine H1 antagonist | Ophthalmic | Antihistamine | Histamine-1 antagonist | APPROVED | false | false | false | false | false | false | false | false | false | S01GX11 | S | S01 | S01G | S01GX | S01GX11 | Sensory organ drugs | Ophthalmologicals | Decongestants and antiallergics | Other antiallergics in atc | Alcaftadine | false | null | null | true | 36 |
EC:00038 | Alclometasone | CHEBI:31184 | DB00240 | [
"Alclometasone dipropionate"
] | [] | Glucocorticoid | Dermatology | Antiinflammatory | Glucocorticoid receptor agonist | APPROVED | false | false | false | false | false | true | false | false | false | D07AB10 | D | D07 | D07A | D07AB | D07AB10 | Dermatologicals | Corticosteroids, dermatological preparations | Corticosteroid dermatological preparations, plain | Corticosteroids, moderately potent (group ii) | Alclometasone | false | null | null | true | 37 |
EC:00039 | Aldesleukin | UNII:M89N0Q7EQR | DB00041 | [] | [] | IL-2 | Targeted cancer therapy | Immunostimulant | Interleukin (human recombinant IL-2) | APPROVED | false | false | false | false | false | false | false | false | false | L03AC01 | L | L03 | L03A | L03AC | L03AC01 | Antineoplastic and immunomodulating agents | Immunostimulants | Immunostimulants | Interleukins | Aldesleukin | false | null | null | false | 38 |
EC:00040 | Alectinib | CHEBI:90936 | DB11363 | [] | [] | ALK inhibitor | Targeted cancer therapy | Small molecule inhibitor | ALK inhibitor | APPROVED | false | false | false | false | false | false | false | false | false | L01ED03 | L | L01 | L01E | L01ED | L01ED03 | Antineoplastic and immunomodulating agents | Antineoplastic agents | Protein kinase inhibitors, antineoplastic and immunomodulating agents | Anaplastic lymphoma kinase (alk) inhibitors | Alectinib | false | null | null | false | 39 |
EC:00041 | Alemtuzumab | UNII:3A189DH42V | DB00087 | [] | [] | Anti-CD52 | Targeted cancer therapy | Monoclonal antibody therapy | Anti-CD52 | APPROVED | false | false | false | false | false | false | false | false | false | L04AG06 | L | L04 | L04A | L04AG | L04AG06 | Antineoplastic and immunomodulating agents | Immunosuppressants | Immunosuppressants | Monoclonal antibodies | Alemtuzumab | false | null | null | false | 40 |
EC:00042 | Alendronic acid | CHEBI:2567 | DB00630 | [
"Alendronate"
] | [] | Bisphosphonate | Musculoskeletal | Inhibit osteoclast-mediated bone resorption | FPPS inhibitor | APPROVED | false | false | false | false | false | false | false | false | false | M05BA04 | M | M05 | M05B | M05BA | M05BA04 | Musculo-skeletal system drugs | Drugs for treatment of bone diseases | Drugs affecting bone structure and mineralization | Bisphosphonate drugs affecting bone structure and mineralization | Alendronic acid | false | null | null | true | 41 |
EC:00043 | Alfentanil | CHEBI:2569 | DB00802 | [] | [] | Opioid | Central nervous system | Analgesic | Mu-opioid receptors | NOT_APPROVED | false | false | false | false | false | false | true | false | false | N01AH02 | N | N01 | N01A | N01AH | N01AH02 | Nervous system drugs | Anesthetics | Anesthetics, general | Opioid anesthetics | Alfentanil | false | null | null | false | 42 |
EC:00044 | Alfuzosin | CHEBI:51141 | DB00346 | [
"Alfuzosin hydrochloride"
] | [] | Alpha blocker | Urological | Smooth muscle relaxer in bladder and prostate | Alpha-1 blockers | APPROVED | false | false | false | false | false | false | false | false | false | G04CA01 | G | G04 | G04C | G04CA | G04CA01 | Genito urinary system and sex hormones | Urologicals | Drugs used in benign prostatic hypertrophy | Alpha-adrenoreceptor antagonists, benign prostatic hypertrophy | Alfuzosin | false | null | null | true | 43 |
EC:00045 | Alglucosidase alfa | UNII:DTI67O9503 | DB01272 | [] | [] | GAA replacement | Metabolic | Lysosomal enzyme replacement | alpha-glucosidase enzyme replacement | APPROVED | false | false | false | false | false | false | false | false | false | A16AB07 | A | A16 | A16A | A16AB | A16AB07 | Alimentary tract and metabolism drugs | Other alimentary tract and metabolism products in atc | Other alimentary tract and metabolism products in atc | Enzymes for alimentary tract and metabolism | Alglucosidase alfa | false | null | null | false | 44 |
EC:00046 | Alirocumab | UNII:PP0SHH6V16 | DB09302 | [] | [] | PCSK9 inhibitor | Cardiovascular | Lipid-lowering | PCSK9 inhibitor | APPROVED | false | false | false | false | false | false | false | true | false | C10AX14 | C | C10 | C10A | C10AX | C10AX14 | Cardiovascular system drugs | Lipid modifying agents | Lipid modifying agents, plain | Other lipid modifying agents in atc | Alirocumab | false | null | null | false | 45 |
EC:00047 | Aliskiren | CHEBI:601027 | DB09026 | [] | [] | Renin inhibitor | Cardiovascular | Antihypertensive | Renin inhibitor | APPROVED | false | false | false | false | false | false | false | true | false | C09XA02 | C | C09 | C09X | C09XA | C09XA02 | Cardiovascular system drugs | Agents acting on the renin-angiotensin system | Other agents acting on the renin-angiotensin system in atc | Renin-inhibitors | Aliskiren | false | null | null | true | 46 |
EC:00048 | Alitretinoin | CHEBI:50648 | DB00523 | [] | [] | Retinoid | Targeted cancer therapy; Dermatology | Vitamin A derivative | retinoid / retinoic acid derivative | NOT_APPROVED | false | false | false | false | false | false | false | false | false | D11AH04 | D | D11 | D11A | D11AH | D11AH04 | Dermatologicals | Other dermatological preparations in atc | Other dermatological preparations in atc | Agents for dermatitis, excluding corticosteroids | Alitretinoin | false | null | null | true | 47 |
EC:00049 | Allopurinol | CHEBI:40279 | DB00437 | [] | [] | Xanthine Oxidase Inhibitor | Musculoskeletal | Antigout agent | decreases uric acid | Xanthine oxidase inhibitor | APPROVED | false | false | false | false | false | false | false | false | false | M04AA01 | M | M04 | M04A | M04AA | M04AA01 | Musculo-skeletal system drugs | Antigout preparations | Antigout preparations | Preparations inhibiting uric acid production | Allopurinol | false | null | null | true | 48 |
EC:00050 | Almotriptan | CHEBI:520985 | DB00918 | [] | [] | Triptan antimigraine | Central nervous system | Antimigraine | selective serotonin (5-HT1) agonist | APPROVED | false | false | false | false | false | false | false | false | false | N02CC05 | N | N02 | N02C | N02CC | N02CC05 | Nervous system drugs | Analgesics | Antimigraine preparations | Selective serotonin (5ht1) agonists | Almotriptan | false | null | null | true | 49 |
EC:00051 | Alogliptin | CHEBI:72323 | DB06203 | [] | [] | DDP-4 inhibitor | Endocrine | Antidiabetic | DDP-4 inhibitor | APPROVED | false | false | false | true | false | false | false | false | false | null | null | null | null | null | null | null | null | null | null | null | false | null | null | false | 50 |
EC:00052 | Alosetron | CHEBI:253342 | DB00969 | [] | [] | Serotonin 5-HT3 antagonist antiemetic | Gastrointestinal | Anti-diarrheal | selective serotonin (5-HT3) antagonist | APPROVED | false | false | false | false | false | false | false | false | false | null | null | null | null | null | null | null | null | null | null | null | false | null | null | true | 51 |
EC:00053 | Alpelisib | CHEBI:93752 | DB12015 | [] | [] | PI3K inhibitor | Targeted cancer therapy | Small molecule inhibitor | PI3K-alpha selective inhibitor | APPROVED | false | false | false | false | false | false | false | false | false | null | null | null | null | null | null | null | null | null | null | null | false | null | null | false | 52 |
EC:00054 | Alpha-1-proteinase inhibitor | DRUGBANK:DB00058 | DB00058 | [
"Human alpha1-proteinase inhibitor"
] | [] | Alpha-1 proteinase inhibitor | Respiratory | Enzyme replacement therapy | Alpha-1 proteinase inhibitor | APPROVED | false | false | false | false | false | false | false | false | false | null | null | null | null | null | null | null | null | null | null | null | false | null | null | false | 53 |
EC:00055 | Alprazolam | CHEBI:2611 | DB00404 | [] | [] | Benzodiazepine | Central nervous system | Sedative | GABA-A agonist | APPROVED | false | true | false | false | false | false | false | false | false | null | null | null | null | null | null | null | null | null | null | null | false | null | null | true | 54 |
EC:00056 | Alprostadil | CHEBI:15544 | DB00770 | [] | [] | Prostaglandin analog | Urological | Vasodilator | prostaglandin E1 analog | APPROVED | false | false | false | false | false | false | false | false | false | null | null | null | null | null | null | null | null | null | null | null | false | null | null | true | 55 |
EC:00057 | Alteplase | UNII:1RXS4UE564 | DB00009 | [] | [] | Plasminogen activator | Hematology | Thombolytic | tissue plasminogen activator | APPROVED | false | false | false | false | false | false | false | false | false | null | null | null | null | null | null | null | null | null | null | null | false | null | null | false | 56 |
EC:00058 | Aluminium hydroxide | CHEBI:33130 | DB06723 | [
"Aluminum hydroxide",
"Algeldrate"
] | [] | Antacid | Gastrointestinal | Antacid | Antacid | APPROVED | false | false | false | false | false | false | false | false | false | null | null | null | null | null | null | null | null | null | null | null | false | null | null | false | 57 |
EC:00059 | Alvimopan | CHEBI:135686 | DB06274 | [] | [] | Peripherally acting mu-opioid receptor antagonists (PAMORAs) | Gastrointestinal | Increase gastric motility | Opioid antagonist | APPROVED | false | false | false | false | false | false | false | false | false | null | null | null | null | null | null | null | null | null | null | null | false | null | null | true | 58 |
EC:00060 | Amantadine | CHEBI:2618 | DB00915 | [
"Amantadine hydrochloride"
] | [] | Amantadine | Central nervous system | Antiparkinson | NMDA receptor agonist | APPROVED | false | false | false | false | false | false | false | false | false | null | null | null | null | null | null | null | null | null | null | null | false | null | null | true | 59 |
EC:00061 | Ambrisentan | CHEBI:135949 | DB06403 | [] | [] | Endothelin receptor antagonist | Respiratory | Vasodilator | Endothelin receptor antagonist | APPROVED | false | false | false | false | false | false | false | false | false | null | null | null | null | null | null | null | null | null | null | null | false | null | null | true | 60 |
EC:00062 | Amcinonide | CHEBI:31199 | DB00288 | [] | [] | Glucocorticoid | Dermatology | Antiinflammatory | Glucocorticoid receptor agonist | APPROVED | false | false | false | false | false | true | false | false | false | null | null | null | null | null | null | null | null | null | null | null | false | null | null | true | 61 |
EC:00063 | Amifampridine | CHEBI:135948 | DB11640 | [] | [] | Neuronal potassium channel blocker | Central nervous system; Peripheral nervous system | Increase acetylcholine release | Potassium channel antagonist | APPROVED | false | false | false | false | false | false | false | false | false | N07XX05 | N | N07 | N07X | N07XX | N07XX05 | Nervous system drugs | Other nervous system drugs in atc | Other nervous system drugs in atc | Other nervous system drugs in atc | Amifampridine | false | null | null | false | 62 |
EC:00064 | Amifostine | CHEBI:2636 | DB01143 | [] | [] | Free radical scavenger | Chemotherapy adjunct | Chemoprotective agent | Free radical scavenger | APPROVED | false | false | false | false | false | false | false | false | false | V03AF05 | V | V03 | V03A | V03AF | V03AF05 | Various drug classes in atc | All other therapeutic products | All other therapeutic products | Detoxifying agents for antineoplastic treatment | Amifostine | false | null | null | false | 63 |
EC:00065 | Amikacin | CHEBI:2637 | DB00479 | [] | [] | Aminoglycoside antibiotic | Antimicrobial | Antibiotic | Aminoglycoside | APPROVED | false | false | true | false | false | false | false | false | false | J01GB06 | J | J01 | J01G | J01GB | J01GB06 | Antiinfectives for systemic use | Antibacterials for systemic use | Aminoglycoside antibacterials | Other aminoglycosides in atc | Amikacin | false | null | null | true | 64 |
EC:00066 | Amiloride | CHEBI:2639 | DB00594 | [
"Amiloride hydrochloride"
] | [] | ENaC Blocker | Cardiovascular; Renal | Diuretic | ENaC antagonist | APPROVED | false | false | false | false | false | false | false | true | false | C03DB01 | C | C03 | C03D | C03DB | C03DB01 | Cardiovascular system drugs | Diuretics | Aldosterone antagonists and other potassium-sparing agents | Other potassium-sparing agents in atc | Amiloride | false | null | null | true | 65 |
EC:00067 | Aminobenzoate potassium | UNII:41KZS5432U | DBSALT002730 | [
"Aminobenzoic acid",
"Vitamin b10",
"Potassium aminobenzoate",
"Potassium p-aminobenzoate"
] | [] | Vitamin B10 | Supplement | Vitamin B supplement | Vitamin B10 | APPROVED | false | false | false | false | false | false | false | false | false | D11AX23 | D | D11 | D11A | D11AX | D11AX23 | Dermatologicals | Other dermatological preparations in atc | Other dermatological preparations in atc | Other dermatological preparations in atc | Aminobenzoate potassium | false | null | null | false | 66 |
EC:00068 | Aminocaproic acid | CHEBI:16586 | DB00513 | [] | [] | Antifibrinolytic | Hematology | Hemostatic agent | Plasminogen antagonist | APPROVED | false | false | false | false | false | false | false | false | false | B02AA01 | B | B02 | B02A | B02AA | B02AA01 | Blood and blood forming organ drugs | Antihemorrhagics | Antifibrinolytics | Antifibrinolytic amino acids | Aminocaproic acid | false | null | null | true | 67 |
EC:00069 | Aminolevulinic acid | CHEBI:17549 | DB00855 | [] | [] | PDT photosensitizer | Targeted cancer therapy; Dermatology | photosensitizing agent | protoporphyrin IX precursor | APPROVED | false | false | false | false | false | false | false | false | false | L01XD04 | L | L01 | L01X | L01XD | L01XD04 | Antineoplastic and immunomodulating agents | Antineoplastic agents | Other antineoplastic agents in atc | Sensitizers used in photodynamic/radiation therapy | Aminolevulinic acid | false | null | null | false | 68 |
EC:00070 | Aminophylline | CHEBI:2659 | DB01223 | [] | [] | Methylxanthine | Respiratory | Bronchodilator | PDE-3A inhibitor | APPROVED | false | false | false | false | false | false | false | false | false | R03DA05 | R | R03 | R03D | R03DA | R03DA05 | Respiratory system drugs | Drugs for obstructive airway diseases | Other systemic drugs for obstructive airway diseases in atc | Xanthines, systemic for obstructive airway disease | Aminophylline | false | null | null | true | 69 |
EC:00071 | Aminosalicylic acid | CHEBI:27565 | DB00233 | [
"Para-aminosalicylic acid",
"4-aminosalicylic acid",
"Aminosalicylate sodium anhydrous"
] | [] | Antimetabolite antitubercular | Antimicrobial | Antibiotic | Antitubercular agent | APPROVED | false | false | true | false | false | false | false | false | false | null | null | null | null | null | null | null | null | null | null | null | false | null | null | true | 70 |
EC:00072 | Amiodarone | CHEBI:2663 | DB01118 | [
"Amiodarone hydrochloride"
] | [] | Class III antiarrhythmic | Cardiovascular | Antiarrhythmic | Potassium channel blocker | APPROVED | false | false | false | false | false | false | false | true | false | C01BD01 | C | C01 | C01B | C01BD | C01BD01 | Cardiovascular system drugs | Cardiac therapy drugs | Antiarrhythmics, class i and iii | Antiarrhythmics, class iii | Amiodarone | false | null | null | true | 71 |
EC:00073 | Amisulpride | CHEBI:64045 | DB06288 | [] | [] | Dopamine antagonist | Gastrointestinal; Central nervous system | Antiemetic | Antipsychotic | Dopamine antagonist | APPROVED | true | false | false | false | false | false | false | false | false | N05AL05 | N | N05 | N05A | N05AL | N05AL05 | Nervous system drugs | Psycholeptics | Antipsychotics | Benzamide antipsychotics | Amisulpride | false | null | null | false | 72 |
EC:00074 | Amitriptyline | CHEBI:2666 | DB00321 | [
"Amitriptyline hydrochloride"
] | [] | Tricyclic antidepressant | Central nervous system | Antidepressant | Serotonin and norepinephrine reuptake inhibitor | APPROVED | false | false | false | false | false | false | false | false | false | N06AA09 | N | N06 | N06A | N06AA | N06AA09 | Nervous system drugs | Psychoanaleptics | Antidepressants | Non-selective monoamine reuptake inhibitors | Amitriptyline | false | null | null | true | 73 |
EC:00075 | Amivantamab | UNII:0JSR7Z0NB6 | DB16695 | [] | [] | Anti-EGFR, Anti-MET bispecific antibody | Targeted cancer therapy | Monoclonal antibody therapy | Anti-EGFR, Anti-MET | APPROVED | false | false | false | false | false | false | false | false | false | L01FX18 | L | L01 | L01F | L01FX | L01FX18 | Antineoplastic and immunomodulating agents | Antineoplastic agents | Monoclonal antibodies and antibody drug conjugates | Other monoclonal antibodies and antibody drug conjugates in atc | Amivantamab | false | null | null | false | 74 |
EC:00076 | Amlodipine | CHEBI:2668 | DB00381 | [] | [] | Dihydropyridine calcium channel blocker | Cardiovascular | Antihypertensive | calcium channel antagonist | APPROVED | false | false | false | false | false | false | false | true | false | C08CA01 | C | C08 | C08C | C08CA | C08CA01 | Cardiovascular system drugs | Calcium channel blockers | Selective calcium channel blockers with mainly vascular effects | Dihydropyridine derivative selective calcium channel blockers with mainly vascular effects | Amlodipine | false | null | null | true | 75 |
EC:00077 | Ammonium lactate | RXCUI:2646433 | DB06768 | [] | [] | Keratolytic | Dermatology | Skin protector | Chemical exfoliant and hydrator | APPROVED | false | false | false | false | false | false | false | false | false | null | null | null | null | null | null | null | null | null | null | null | false | null | null | true | 76 |
EC:00078 | Amobarbital | CHEBI:2673 | DB01351 | [] | [] | Barbiturate | Central nervous system | Sedative | Barbiturate | NOT_APPROVED | false | true | false | false | false | false | false | false | false | N05CA02 | N | N05 | N05C | N05CA | N05CA02 | Nervous system drugs | Psycholeptics | Hypnotics and sedatives | Barbiturates, hypnotics and sedatives, plain | Amobarbital | false | null | null | false | 77 |
EC:00079 | Amorolfine | CHEBI:599440 | DB09056 | [
"Amorolfin"
] | [] | Topical antifungal | Antimicrobial; Dermatology | Antifungal | Ergosterol synthesis inhibitor | NOT_APPROVED | false | false | true | false | false | false | false | false | false | D01AE16 | D | D01 | D01A | D01AE | D01AE16 | Dermatologicals | Antifungals for dermatological use | Antifungals for topical use | Other antifungals for topical use in atc | Amorolfine | false | null | null | false | 78 |
EC:00080 | Amoxapine | CHEBI:2675 | DB00543 | [] | [] | Tricyclic antidepressant | Central nervous system | Antidepressant | Tricyclic antidepressant | APPROVED | false | false | false | false | false | false | false | false | false | N06AA17 | N | N06 | N06A | N06AA | N06AA17 | Nervous system drugs | Psychoanaleptics | Antidepressants | Non-selective monoamine reuptake inhibitors | Amoxapine | false | null | null | true | 79 |
EC:00081 | Amoxicillin | CHEBI:2676 | DB01060 | [] | [] | Penicillin | Antimicrobial | Antibiotic | Penicillin | APPROVED | false | false | true | false | false | false | false | false | false | J01CA04 | J | J01 | J01C | J01CA | J01CA04 | Antiinfectives for systemic use | Antibacterials for systemic use | Beta-lactam antibacterials, penicillins | Penicillins with extended spectrum | Amoxicillin | false | null | null | true | 80 |
EC:00082 | Amphetamine | CHEBI:132233 | DB00182 | [] | [] | Amphetamine and derivatives | Central nervous system | CNS Stimulant | centrally acting sympathomimetics | APPROVED | false | false | false | false | false | false | false | false | false | null | null | null | null | null | null | null | null | null | null | null | false | null | null | true | 81 |
EC:00083 | Amphotericin b | CHEBI:2682 | DB00681 | [] | [] | Polyene antifungal | Antimicrobial | Antifungal | Binds ergosterol | APPROVED | false | false | true | false | false | false | false | false | false | J02AA01 | J | J02 | J02A | J02AA | J02AA01 | Antiinfectives for systemic use | Antimycotics for systemic use | Antimycotics for systemic use | Antibiotics for systemic use | Amphotericin b | false | null | null | true | 82 |
EC:00084 | Ampicillin | CHEBI:28971 | DB00415 | [] | [] | Penicillin | Antimicrobial | Antibiotic | Penicillin | APPROVED | false | false | true | false | false | false | false | false | false | J01CA01 | J | J01 | J01C | J01CA | J01CA01 | Antiinfectives for systemic use | Antibacterials for systemic use | Beta-lactam antibacterials, penicillins | Penicillins with extended spectrum | Ampicillin | false | null | null | true | 83 |
EC:00085 | Amsacrine | CHEBI:2687 | DB00276 | [] | [] | Topoisomerase II inhibitor | Traditional cancer therapy | Topoisomerase inhibitor | Topoisomerase II inhibitor | NOT_APPROVED | false | false | false | false | true | false | false | false | false | L01XX01 | L | L01 | L01X | L01XX | L01XX01 | Antineoplastic and immunomodulating agents | Antineoplastic agents | Other antineoplastic agents in atc | Other antineoplastic agents in atc | Amsacrine | false | null | null | false | 84 |
EC:00086 | Anagrelide | CHEBI:142290 | DB00261 | [] | [] | PDE-3 inhibitor | Hematology | Antiplatelet | PDE-3 inhibitor | APPROVED | false | false | false | false | false | false | false | false | false | L01XX35 | L | L01 | L01X | L01XX | L01XX35 | Antineoplastic and immunomodulating agents | Antineoplastic agents | Other antineoplastic agents in atc | Other antineoplastic agents in atc | Anagrelide | false | null | null | true | 85 |
EC:00087 | Anakinra | UNII:9013DUQ28K | DB00026 | [] | [] | IL-1 pathway inhibitor | Immune | Cytokine therapy | IL-1 receptor antagonist | APPROVED | false | false | false | false | false | false | false | false | false | L04AC03 | L | L04 | L04A | L04AC | L04AC03 | Antineoplastic and immunomodulating agents | Immunosuppressants | Immunosuppressants | Interleukin inhibitors | Anakinra | false | null | null | false | 86 |
EC:00088 | Anastrozole | CHEBI:2704 | DB01217 | [] | [] | Aromatase inhibitor | Targeted cancer therapy | Hormonal chemotherapy | Aromatase inhibitor | APPROVED | false | false | false | false | false | false | false | false | false | L02BG03 | L | L02 | L02B | L02BG | L02BG03 | Antineoplastic and immunomodulating agents | Endocrine therapy antineoplastic and immunomodulating agents | Hormone antagonists and related agents | Aromatase inhibitors | Anastrozole | false | null | null | true | 87 |
EC:00089 | Angiotensin ii | CHEBI:2719 | DB11842 | [
"Synthetic angiotensin ii",
"Angiotensin ii (human)"
] | [] | Angiotensin II | Cardiovascular | Vasoactive Agent | Peptide hormone analog | APPROVED | false | false | false | false | false | false | false | true | false | C01CX09 | C | C01 | C01C | C01CX | C01CX09 | Cardiovascular system drugs | Cardiac therapy drugs | Cardiac stimulants excl. cardiac glycosides | Other cardiac stimulants in atc | Angiotensin ii | false | null | null | true | 88 |
EC:00090 | Anidulafungin | CHEBI:55346 | DB00362 | [] | [] | Echinocandin antifungal | Antimicrobial | Antifungal | Beta-glucan synthesis inhibitor | APPROVED | false | false | true | false | false | false | false | false | false | J02AX06 | J | J02 | J02A | J02AX | J02AX06 | Antiinfectives for systemic use | Antimycotics for systemic use | Antimycotics for systemic use | Other antimycotics for systemic use in atc | Anidulafungin | false | null | null | false | 89 |
EC:00091 | Anifrolumab | UNII:38RL9AE51Q | DB11976 | [] | [] | IFNAR inhibitor | Immune | Antiinflammatory | IFNAR inhibitor | APPROVED | false | false | false | false | false | false | false | false | false | L04AG11 | L | L04 | L04A | L04AG | L04AG11 | Antineoplastic and immunomodulating agents | Immunosuppressants | Immunosuppressants | Monoclonal antibodies | Anifrolumab | false | null | null | false | 90 |
EC:00092 | Ansuvimab | UNII:TG8IQ19NG2 | DB16385 | [] | [] | Anti-ebola antibody | Antimicrobial | Antiviral | Ebola | APPROVED | false | false | true | false | false | false | false | false | false | null | null | null | null | null | null | null | null | null | null | null | false | null | null | false | 91 |
EC:00093 | Anthralin | CHEBI:37510 | DB11157 | [
"Dithranol"
] | [] | Keratolytic | Dermatology | Inhibit keratinocyte proliferation | null | APPROVED | false | false | false | false | false | false | false | false | false | null | null | null | null | null | null | null | null | null | null | null | false | null | null | false | 92 |
EC:00094 | Anti-d immunoglobulin | UMLS:C5192004 | DB11597 | [
"Human rho(d) immune globulin",
"Anti-d (rh0) immunoglobulin"
] | [] | Anti-D immunoglobulin | Hematology | Immunomodulator | Anti-D immunoglobulin | APPROVED | false | false | false | false | false | false | false | false | false | null | null | null | null | null | null | null | null | null | null | null | false | null | null | false | 93 |
EC:00095 | Antithrombin alfa | UMLS:C2316217 | DB11166 | [
"Antithrombin",
"Antithrombin iii human",
"Antithrombin iii"
] | [] | Antithrombin replacement | Hematology | Anticoagulant | Antithrombin replacement | APPROVED | false | false | false | false | false | false | false | false | false | null | null | null | null | null | null | null | null | null | null | null | false | null | null | false | 94 |
EC:00096 | Apadamtase alfa | UMLS:C4547518 | DB15164 | [
"Adamts13"
] | [] | ADAMTS13 replacement | Hematology | Thrombolytic | Recombinant human ADAMTS13 | APPROVED | false | false | false | false | false | false | false | false | false | null | null | null | null | null | null | null | null | null | null | null | false | null | null | false | 95 |
EC:00097 | Apalutamide | UNII:4T36H88UA7 | DB11901 | [] | [] | Androgen receptor inhibitor | Targeted cancer therapy | Hormonal chemotherapy | Androgen receptor inhibitor | APPROVED | false | false | false | false | false | false | false | false | false | L02BB05 | L | L02 | L02B | L02BB | L02BB05 | Antineoplastic and immunomodulating agents | Endocrine therapy antineoplastic and immunomodulating agents | Hormone antagonists and related agents | Anti-androgen hormone antagonists and related agents | Apalutamide | false | null | null | true | 96 |
EC:00098 | Apixaban | CHEBI:72296 | DB06605 | [] | [] | Direct oral factor Xa inhibitor | Hematology | Anticoagulant | Direct oral factor Xa inhibitor | APPROVED | false | false | false | false | false | false | false | false | false | B01AF02 | B | B01 | B01A | B01AF | B01AF02 | Blood and blood forming organ drugs | Antithrombotic agents | Antithrombotic agents | Direct factor xa inhibitors | Apixaban | false | null | null | true | 97 |
EC:00099 | Apomorphine | CHEBI:48538 | DB00714 | [
"Apomorphine hydrochloride"
] | [] | Dopamine agonist | Central nervous system | Antiparkinson | Dopamine agonist | APPROVED | false | false | false | false | false | false | false | false | false | N04BC07 | N | N04 | N04B | N04BC | N04BC07 | Nervous system drugs | Anti-parkinson drugs | Dopaminergic agents | Dopamine agonists | Apomorphine | false | null | null | true | 98 |
EC:00100 | Apraclonidine | CHEBI:2788 | DB00964 | [] | [] | Alpha-adrenergic agonist | Ophthalmic | Reduce IOP | decrease aqueous humor production | Alpha-2 agonist | APPROVED | false | false | false | false | false | false | false | false | false | S01EA03 | S | S01 | S01E | S01EA | S01EA03 | Sensory organ drugs | Ophthalmologicals | Antiglaucoma preparations and miotics | Sympathomimetics in glaucoma therapy | Apraclonidine | false | null | null | true | 99 |
End of preview. Expand in Data Studio
Dataset Card for Every Cure Drug List
Dataset Summary
The Every Cure Drug List is a manually curated list of drug entities used by the MATRIX project for drug repurposing predictions. For reference, the list contains ~1,800 drugs with metadata including approval status, drug class flags, therapeutic annotations, and ATC classifications.
For more information see here.
Source Data
- Downloads last month
- 64